Travere Therapeutics, Inc. (TVTX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2012: $5.80M2013: $40.17M2014: $172.72M2015: $212.29M2016: $217.51M2017: $227.21M2018: $390.91M2019: $383.60M2020: $396.23M2021: $474.52M2022: $629.73M2023: $588.10M2024: $535.05M2025: $490.36M$490.36M
2012Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$490.36M-8.4%
2024$535.05M-9.0%
2023$588.10M-6.6%
2022$629.73M+32.7%
2021$474.52M+19.8%
2020$396.23M+3.3%
2019$383.60M-1.9%
2018$390.91M+72.0%
2017$227.21M+4.5%
2016$217.51M+2.5%
2015$212.29M+22.9%
2014$172.72M+330.0%
2013$40.17M+592.6%
2012$5.80M